CRT shown highly cost effective in mild heart failure Family Practice News Digital Network DALLAS – Cardiac resynchronization therapy demonstrated a robust cost-effectiveness of $18,275 per quality-adjusted life-year gained in an analysis from the landmark REVERSE trial. REVERSE (Resynchronization Reverses Remodeling in Systolic Left ... |
